KM Biologics plays a key role in safeguarding the health of Japan’s population, developing cutting-edge vaccines and blood-plasma products, and screening newborn babies.
Takuya Maoka, President of KNC Laboratories, discusses the dynamic landscape of the Japanese chemical industry, emphasizing a shift towards specialization, particularly in semiconductor chemicals. In...
Specializing in healthcare and life sciences, Dojin is poised to be a key player not only in the Japanese biotechnology field, but worldwide as it leverages the synergistic benefits of its group company...
Due to the pronounced economic crisis that has beaten the stability of several economies at an international level, the investment efforts in research and development have dramatically fallen, and have...
